Experience

Pliant Therapeutics – $230.0 Million Follow-on Offering

August 24, 2022

Cooley advised the underwriters in Pliant Therapeutics’ $230.0 million follow-on offering of 12,432,432 shares of common stock at a public offering price of $18.50 per share. Pliant is a clinical-stage biotechnology company discovering and developing novel therapies for the treatment of fibrosis. Partners Denny Won, Charlie Kim, Kristin VanderPas and Dave Peinsipp led the Cooley team.

Related contacts

Denny Won
Partner, San Francisco
Charlie Kim
Partner, San Diego
Kristin VanderPas
Partner, San Francisco
David Peinsipp
Partner, San Francisco
Valerie Sapozhnikova
Associate, Los Angeles Downtown
Madison (JJ) Meng
Associate, San Francisco
Marjorie Roesser
Associate, San Francisco

Sweetgreen – $418.6 Million IPO

December 6, 2021

Cooley advised restaurant chain sweetgreen on its $418.6 million initial public offering of 14,950,000 shares of Class A common stock, which now trade on the New York Stock Exchange under the symbol SG. Partners Nick Hobson, David Peinsipp, Siana Lowrey and Charlie Kim led the Cooley team advising sweetgreen.

Read more

Related contacts

Nick Hobson
Partner, Los Angeles Santa Monica
David Peinsipp
Partner, San Francisco
Siana Lowrey
Partner, San Francisco
Charlie Kim
Partner, San Diego
Julia Boesch
Associate, San Francisco
Mark Cikowski
Associate, Los Angeles Santa Monica
Marjorie Roesser
Associate, San Francisco
Madeleine Smith
Associate, San Francisco
Eric Steiner
Paralegal Specialist, San Francisco
Amy Saldamando
Paralegal Specialist, Los Angeles Santa Monica
Kim Merritt
Paralegal Specialist, San Francisco
Barbara Mirza
Partner, Los Angeles Santa Monica
Austin Holt
Associate, Los Angeles Santa Monica
David Navetta
Partner, Colorado
Christian Lee
Associate, San Francisco
Maricel Mojares-Moore
Special Counsel, San Francisco
Matt Kong
Associate, San Francisco
Ross Eberly
Partner, Los Angeles Santa Monica
Eileen Leman
Associate, Los Angeles Downtown
Karen Tsai
Special Counsel, Washington DC
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Stephanie Gentile
Partner, New York
John Paul Oleksiuk
Partner, New York
Colette Ghazarian
Associate, Los Angeles Downtown
Sharon Connaughton
Special Counsel, Washington DC
Patrick Gibbs
Partner, Palo Alto
Francis Wheeler
Partner, Colorado
Michael Suyat
Senior Paralegal, San Francisco

Lulu’s – $92 Million IPO

November 17, 2021

Cooley advised the underwriters on fashion brand Lulu’s $92 million initial public offering of 5,750,000 shares of common stock, which now trade on the Nasdaq Global Market under the symbol LVLU. Lawyers David Peinsipp, Kristin VanderPas and Denny Won led the Cooley team advising the underwriters.

Read more

Related contacts

David Peinsipp
Partner, San Francisco
Kristin VanderPas
Partner, San Francisco
Denny Won
Partner, San Francisco
Valerie Sapozhnikova
Associate, Los Angeles Downtown
Alexander Davis
Associate, San Diego
Marjorie Roesser
Associate, San Francisco
Lila Hope
Partner, Palo Alto
Jennifer Raab
Special Counsel, Palo Alto
Bobby Ghajar
Partner, Los Angeles Santa Monica
TJ Graham
Partner, Palo Alto
Caitlin Courtney
Associate, Palo Alto
Genevieve Lim Urban
Associate, Seattle
Barbara Mirza
Partner, Los Angeles Santa Monica
Randy Sabett
Special Counsel, Washington DC
Aaron Pomeroy
Partner, Colorado
Rick Jantz
Associate, Los Angeles Santa Monica
Rebecca Ross
Special Counsel, Washington DC
Francis Wheeler
Partner, Colorado
Drew Williamson
Partner, San Francisco

PROCEPT BioRobotics – $188.5 Million IPO

September 15, 2021

Cooley advised the underwriters on PROCEPT BioRobotics’ $188.5 million initial public offering of 7,539,400 shares of common stock, which includes the full exercise of the underwriters’ option to purchase additional shares. BofA Securities, Inc. and Goldman Sachs & Co. LLC acted as joint lead book-running managers for the offering. PROCEPT BioRobotics, whose securities now trade on the Nasdaq Global Market under the symbol “PRCT,” is a commercial-stage surgical robotics company focused on advancing patient care by developing transformative solutions in urology. Partners Charlie Kim, Kristin VanderPas and Dave Peinsipp led the Cooley team.

Related contacts

Charlie Kim
Partner, San Diego
Kristin VanderPas
Partner, San Francisco
David Peinsipp
Partner, San Francisco
Denny Won
Partner, San Francisco
David D. Kim
Associate, San Francisco
Kyle Huh
Associate, Palo Alto
Marjorie Roesser
Associate, San Francisco

Doximity – $697 Million IPO

June 24, 2021

Related contacts

David Peinsipp
Partner, San Francisco
Charlie Kim
Partner, San Diego
Kristin VanderPas
Partner, San Francisco
Denny Won
Partner, San Francisco
Christine Turner
Associate, Colorado
Marjorie Roesser
Associate, San Francisco
View more